Oxford Brain Diagnostics touts study on FTD pathology
AuntMinnie13 Oct · 04:34← All topics · now
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
SynBioBeta13 Oct · 03:44
Development ↘
Right now
Researchers are using brain-disease studies to improve understanding of frontotemporal dementia.
20 reports · 13 Oct
Summary · from headlines6 points
- Global study reports 11.4 million new dementia cases in 2023 and projects 24.7 million per year by 2050.
- Study offers new clues about how genetic risk for Alzheimer's affects brain immune cells.
- New study links a fat in olive oil to slower Alzheimer's progression.
- ARPA-H awards up to $51.7 million to predict protein misfolding before disease begins.
- Post Translational Medicines joins ARPA-H's BIOGAMI Team to track and reverse protein states behind neurodegeneration.
- Oxford Brain Diagnostics touts a study on FTD pathology.
Latest developments6 to read first
US consortium gets up to $51.7m for protein misfolding research
UA.NEWS13 Oct · 04:14Adult ADHD Tied to Fourfold Higher Risk for MCI, Dementia
Medscape13 Oct · 03:54Nautilus Biotechnology to join ARPA-H backed SEEDS consortium to study disease protein misfolding
Traders Union13 Oct · 03:44Scientists Receive Up to $51.7 Million to Predict Protein Misfolding Before Disease Begins
Bioengineer.org13 Oct · 03:14Timeline 20 reports
13 Oct 202620 reportsToday
04:002 reports
03:007 reports
02:005 reports
01:00nothing heard
00:006 reports
← All topics · nowOne topic